Glycomine is a company that provides Pharmacy and Therapeutics, NGLY1, Enzyme replacement therapy and more. Glycomine is headquartered in United States California. Glycomine was founded in 2013. and was founded by Agnes Rafalko. Glycomine has a total of 41 patents
Related Topics
Pharmacy and TherapeuticsNGLY1Enzyme replacement therapyObservational studyTherapeutic approachLigandEnzymeMoleculeCell
A quick overview of tech portfolio with the top keywords and phrases extracted from patents of Glycomine
Download
High Related Markets
Mentioned companies in the market reports of major market categories and sectors by Glycomine
Sign up to view the full data
Free Trial Now
Download
Innovation Matrix
visualizing technology portfolio of hot application areas and blank areas for Glycomine
Time Range:
Overall
Overall
1 year
3 year
5 year
Application Domain L2
Application Domain L2
Application Domain L3
Application Domain L4
High-Tech Industry L1
High-Tech Industry L2
Tech Topic L2
Tech Topic L3
Timeline
Tech Topic L2
Tech Topic L2
Tech Topic L3
High-Tech Industry L1
High-Tech Industry L2
Application Domain L2
Application Domain L3
Application Domain L4
Download
Subsidiary Lists
Subsidiaries with patent applications for Glycomine
Sign up to view the full data
Free Trial Now
Download
Top Related Companies
Sign up to view the full data
Free Trial Now
Glycomine Frequently Asked Questions
What is Glycomine's industry?
Glycomine is in the industry of:Research and Development in the Physical, Engineering, and Life Sciences
What technical fields has Glycomine researched?
Glycomine has researched the technical fields related toPharmacy and TherapeuticsNGLY1Enzyme replacement therapyObservational studyTherapeutic approachLigandEnzymeMoleculeCell
Glycomine, Inc. engages in the development of therapeutics for diseases which have no treatment options. Its therapeutic approach is to combine replacement...
What is Glycomine's official website?
Glycomine's official website is http://glycomine.com/.